No Data
No Data
Navigating 7 Analyst Ratings For Chemours
Chemours Is Maintained at Equal-Weight by Barclays
Take Care Before Diving Into The Deep End On The Chemours Company (NYSE:CC)
Chemours (NYSE:CC) Investors Are up 5.8% in the Past Week, but Earnings Have Declined Over the Last Five Years
Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $21
Express News | Chemours : Barclays Cuts Target Price to $21 From $22